Eidos Therapeutics is a clinical research site located in San Francisco, California, United States 94104.
Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.
Eidos Therapeutics has participated in 1 clinical trials.
Therapeutic areas: Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy.
Sponsors: Eidos Therapeutics, a BridgeBio company.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in California · View every site in San Francisco
Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Eidos Therapeutics has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Eidos Therapeutics has 1 clinical trials on record. Their work covers Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy.
Eidos Therapeutics has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.